Accéder au contenu
Merck
  • A diagnostic conundrum: acute interstitial nephritis due to armodafinil versus acute cellular rejection in a renal transplant recipient--a case report.

A diagnostic conundrum: acute interstitial nephritis due to armodafinil versus acute cellular rejection in a renal transplant recipient--a case report.

Transplantation proceedings (2013-03-19)
K M Baradhi, R Gohh
RÉSUMÉ

Acute interstitial nephritis is a well-recognized cause of acute kidney injury in native kidneys. While the most common etiology being drug-induced, other causes are infectious, autoimmune, and idiopathic forms of disease. Drug-induced acute interstitial nephritis is not only uncommon in renal transplant recipients but is difficult to diagnose as it mimics acute cellular rejection histologically. We have described herein a renal transplant recipient with acute kidney injury to highlight the difficulties to distinguish acute interstitial nephritis from acute cellular rejection.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Modafinil, ≥98% (HPLC)
Supelco
Modafinil solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Modafinil, European Pharmacopoeia (EP) Reference Standard
Modafinil for system suitability, European Pharmacopoeia (EP) Reference Standard